Effects of SCOPARONE (cas 120-08-1) on dopamine release in PC12 cells
-
Add time:09/04/2019 Source:sciencedirect.com
The effects of SCOPARONE (cas 120-08-1) on dopamine release in PC12 cells were investigated. Scoparone at 50–200 µM increased dopamine release into the culture medium. However, the released levels of dopamine by scoparone were not altered in the absence of extracellular Ca2+ and by adenylyl cyclase inhibitor MDL-12,330A. Scoparone increased phosphorylation of PKA, CaMK II and synapsin I. Scoparone also enhanced K+-induced levels of dopamine release by CaMK II phosphorylation. These results suggest that scoparone increases dopamine release by synapsin I phosphorylation via activation of PKA and CaMK II, which are mediated by cyclic AMP levels and Ca2+ influx.
We also recommend Trading Suppliers and Manufacturers of SCOPARONE (cas 120-08-1). Pls Click Website Link as below: cas 120-08-1 suppliers
Prev:Protective effects of SCOPARONE (cas 120-08-1) against lipopolysaccharide-induced acute lung injury
Next:Analytical MethodsSCOPARONE (cas 120-08-1) inhibits adipocyte differentiation through down-regulation of peroxisome proliferators-activated receptor γ in 3T3-L1 preadipocytes) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Research ArticleSCOPARONE (cas 120-08-1) attenuates RANKL-induced osteoclastic differentiation through controlling reactive oxygen species production and scavenging09/06/2019
- Analytical MethodsSCOPARONE (cas 120-08-1) inhibits adipocyte differentiation through down-regulation of peroxisome proliferators-activated receptor γ in 3T3-L1 preadipocytes09/05/2019
- Protective effects of SCOPARONE (cas 120-08-1) against lipopolysaccharide-induced acute lung injury09/03/2019
- SCOPARONE (cas 120-08-1) attenuates hepatic stellate cell activation through inhibiting TGF-β/Smad signaling pathway09/02/2019
- Full length articleSCOPARONE (cas 120-08-1) attenuates high glucose-induced extracellular matrix accumulation in rat mesangial cells09/01/2019
- SCOPARONE (cas 120-08-1) prevents IL-1β-induced inflammatory response in human osteoarthritis chondrocytes through the PI3K/Akt/NF-κB pathway08/31/2019
- Original articleTherapeutic effects of SCOPARONE (cas 120-08-1) on pilocarpine (Pilo)-induced seizures in mice08/30/2019
- Full paperSCOPARONE (cas 120-08-1) attenuates angiotensin II-induced extracellular matrix remodeling in cardiac fibroblasts08/29/2019
- Structure properties of SCOPARONE (cas 120-08-1): Polymorphs and cocrystals08/28/2019
